These findings suggest that targeting MAT2A for methionine intervention could reverse the CD8A+ T cell deficiency in the immune-suppressive microenvironment of MTAP-deleted OS, thereby enhancing its sensitivity to ICT. The gene discussed is MTAP; the disease is congenital T-cell immunodeficiency.